Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.


Autoria(s): Pilat N.; Klaus C.; Gattringer M.; Jaeckel E.; Wrba F.; Golshayan D.; Baranyi U.; Wekerle T.
Data(s)

2011

Identificador

http://serval.unil.ch/?id=serval:BIB_9BDC188C0931

isbn:1534-6080 (Electronic)

pmid:21697774

doi:10.1097/TP.0b013e3182241133

isiid:000293176300009

Idioma(s)

en

Fonte

Transplantation, vol. 92, no. 3, pp. 280-288

Palavras-Chave #Adoptive Transfer/methods; Animals; Bone Marrow Transplantation/methods; Female; Green Fluorescent Proteins/genetics; Immune Tolerance/immunology; Immunosuppressive Agents/pharmacology; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Radiation Dosage; Sirolimus/pharmacology; Skin Transplantation/methods; T-Lymphocytes, Regulatory/drug effects; T-Lymphocytes, Regulatory/radiation effects; Transplantation Chimera/immunology; Transplantation Conditioning/methods; Whole-Body Irradiation
Tipo

info:eu-repo/semantics/article

article